Active Biotech AB

Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer.
Quotes
- Bid
- Ask
- Open
- Previous close
- Volume
- Relative volume
- High
- Low
Returns
Key stats
ESG risk
ESG risk is a measure of how well a company manages material ESG risks. Sustainalytics’ ESG risk category is designed to help investors identify and understand financially material ESG risks at the company level and how they might affect the long-term performance for equity investments. The scale is from 0-100. The lower the risk, the better (0 is equivalent to no risk and 100 the most severe).
Download ESG risk methodology (PDF)Financials
About Active Biotech AB
Active Biotech AB focuses on the research and development of pharmaceuticals products within medical areas including neurodegenerative diseases, autoimmune/inflammatory disease and various forms of cancer. Its project portfolio contains both small molecules that are orally active immunomodulatory agents and antibody based immunotherapy.
Frequently asked questions
To buy Active Biotech AB stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Active Biotech AB by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Active Biotech AB is ACTI:xome. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Active Biotech AB has its primary listing on NASDAQ OMX Stockholm. You can trade Active Biotech AB with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Active Biotech AB is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Active Biotech AB as part of a broader investment portfolio.